Taft Chicago partners Steve Auten and Roshan Shrestha, Ph.D., will present “Recent Cases and Trends in US Litigation” at the IpEssentia webinar on Nov. 27 at 10 p.m. CST (Nov. 28 at 9:30 a.m. IST). The webinar will cover the Supreme Court ruling in Amgen v. Sanofi and other recent cases involving invalidity.
To register, please contact Roshan or Steve here. For more information on the webinar, click here.
Steve is the chair of Taft’s Pharmaceutical and Life Sciences Litigation group. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators, and others on his LinkedIn blog, “Hatch Waxman ANDA Litigation Forum,” which has more than 14,000 members worldwide. Auten represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities.
Roshan focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution, and opinion work in the chemical, pharmaceutical, and electronic material arts. He has a broad scope of pharmaceutical and life sciences capabilities, including Hatch-Waxman litigation and inter partes review proceedings at the USPTO. Roshan has been recognized by Super Lawyers and/or Leading Lawyers Network since 2014 and was named to Law Bulletin’s “40 Illinois Attorneys Under 40 to Watch”.